ScholarIQanswers from OpenAlex & ORCID
Harry W. Herr
ResearcherPublications, citations & collaboration network
Harry W. Herr is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Harry W. Herr have?
ScholarIQindexed works
Harry W. Herr has 711 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Harry W. Herr have?
ScholarIQcitation count
Harry W. Herr has 42,045 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Harry W. Herr?
ScholarIQh-index
Harry W. Herr has an h-index of 106 in OpenAlex.
What is the i10-index of Harry W. Herr?
ScholarIQi10-index
Harry W. Herr has an i10-index of 401 in OpenAlex.
What is the OpenAlex record for Harry W. Herr?
ScholarIQopenalex
The OpenAlex for Harry W. Herr is on the source record.
What are the most-cited papers on Harry W. Herr?
ScholarIQmost cited works
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Rick Bangs, Rick Bangs, Jovan Begovic, Jason Brown, Mark K. Buyyounouski, Kevin Chan, Paul Chang, Arnold I. Chin, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Hristos Kaimakliotis, Shilajit Kundu, Subodh M. Lele, Amy Luckenbaugh, Jonathan Maldonado, Lin Mei, Jeffrey S. Montgomery, Mamta Parikh, Anthony Patterson, Charles Peyton, Elizabeth R. Plimack, Mark A. Preston, Kyle Richards, Steven Seyedin, Arlene O. Siefker‐Radtke, Tyler Stewart, Debasish Sundi, Umang Swami, Matthew Tollefson, Jonathan L. Wright, Carly J. Cassara, Bailee Sliker
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
Bernard H. Bochner, Guido Dalbagni, Daniel D. Sjoberg, Jonathan Silberstein, Gal E. Keren Paz, S. Machele Donat, Jonathan Coleman, Sheila Mathew, Andrew J. Vickers, Geoffrey Schnorr, Michael Feuerstein, Bruce D. Rapkin, Raul O. Parra, Harry W. Herr, Vincent P. Laudone
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma, Yu Shen, Sijin Wen, Sachiko Yamada, Achim A. Jungbluth, Sacha Gnjatic, Dean F. Bajorin, Victor E. Reuter, Harry W. Herr, Lloyd J. Old, Eiichi Sato
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
Guillaume Ploussard, Siamak Daneshmand, Jason A. Efstathiou, Harry W. Herr, Nicholas D. James, Claus Rödel, Shahrokh F. Shariat, William U. Shipley, Cora N. Sternberg, George N. Thalmann, Wassim Kassouf
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Kevin Chan, Sam S. Chang, Terence W. Friedlander, Richard E. Greenberg, Khurshid A. Guru, Harry W. Herr, Jean Hoffman‐Censits, Amar U. Kishan, Shilajit Kundu, Subodh M. Lele, Ronac Mamtani, Vitaly Margulis, Omar Y. Mian, Jeff M. Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Kyle A. Richards, Wade J. Sexton, Arlene O. Siefker‐Radtke, Matthew K. Tollefson, Jonathan D. Tward, Jonathan L. Wright, Mary A. Dwyer, Carly J. Cassara, Lisa A. Gurski